Literature DB >> 22863420

Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice.

Frederic A Carvalho1, Omry Koren, Julia K Goodrich, Malin E V Johansson, Ilke Nalbantoglu, Jesse D Aitken, Yueju Su, Benoit Chassaing, William A Walters, Antonio González, Jose C Clemente, Tyler C Cullender, Nicolas Barnich, Arlette Darfeuille-Michaud, Matam Vijay-Kumar, Rob Knight, Ruth E Ley, Andrew T Gewirtz.   

Abstract

Colitis results from breakdown of homeostasis between intestinal microbiota and the mucosal immune system, with both environmental and genetic influencing factors. Flagellin receptor TLR5-deficient mice (T5KO) display elevated intestinal proinflammatory gene expression and colitis with incomplete penetrance, providing a genetically sensitized system to study the contribution of microbiota to driving colitis. Both colitic and noncolitic T5KO exhibited transiently unstable microbiotas, with lasting differences in colitic T5KO, while their noncolitic siblings stabilized their microbiotas to resemble wild-type mice. Transient high levels of proteobacteria, especially enterobacteria species including E. coli, observed in close proximity to the gut epithelium were a striking feature of colitic microbiota. A Crohn's disease-associated E. coli strain induced chronic colitis in T5KO, which persisted well after the exogenously introduced bacterial species had been eliminated. Thus, an innate immune deficiency can result in unstable gut microbiota associated with low-grade inflammation, and harboring proteobacteria can drive and/or instigate chronic colitis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863420      PMCID: PMC4310462          DOI: 10.1016/j.chom.2012.07.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  38 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

2.  Altered gut microbiota composition in immune-impaired Nod2(-/-) mice.

Authors:  Stanislas Mondot; Frédérick Barreau; Ziad Al Nabhani; Monique Dussaillant; Karine Le Roux; Joël Doré; Marion Leclerc; Jean-Pierre Hugot; Patricia Lepage
Journal:  Gut       Date:  2011-08-25       Impact factor: 23.059

3.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota.

Authors:  Alan W Walker; Jennifer Ince; Sylvia H Duncan; Lucy M Webster; Grietje Holtrop; Xiaolei Ze; David Brown; Mark D Stares; Paul Scott; Aurore Bergerat; Petra Louis; Freda McIntosh; Alexandra M Johnstone; Gerald E Lobley; Julian Parkhill; Harry J Flint
Journal:  ISME J       Date:  2010-08-05       Impact factor: 10.302

4.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

5.  Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice.

Authors:  Kabir S Matharu; Emiko Mizoguchi; Carmen Alonso Cotoner; Deanna D Nguyen; Bethany Mingle; Onyinye I Iweala; Megan E McBee; Andrew T Stefka; Guenolee Prioult; Kevin M Haigis; Atul K Bhan; Scott B Snapper; Hidehiro Murakami; David B Schauer; Hans-Christian Reinecker; Atsushi Mizoguchi; Cathryn R Nagler
Journal:  Gastroenterology       Date:  2009-08-03       Impact factor: 22.682

6.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

Authors:  A Darfeuille-Michaud; C Neut; N Barnich; E Lederman; P Di Martino; P Desreumaux; L Gambiez; B Joly; A Cortot; J F Colombel
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

7.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

Authors:  Claudia Lupp; Marilyn L Robertson; Mark E Wickham; Inna Sekirov; Olivia L Champion; Erin C Gaynor; B Brett Finlay
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

8.  Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Amrita Kumar; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Andrew T Gewirtz
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

9.  Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles.

Authors:  M L Gilmor; N R Nash; A Roghani; R H Edwards; H Yi; S M Hersch; A I Levey
Journal:  J Neurosci       Date:  1996-04-01       Impact factor: 6.167

10.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.

Authors:  Alan W Walker; Jeremy D Sanderson; Carol Churcher; Gareth C Parkes; Barry N Hudspith; Neil Rayment; Jonathan Brostoff; Julian Parkhill; Gordon Dougan; Liljana Petrovska
Journal:  BMC Microbiol       Date:  2011-01-10       Impact factor: 3.605

View more
  210 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

2.  Intestinal bacterial biofilms modulate mucosal immune responses.

Authors:  Melissa Ellermann; R Balfour Sartor
Journal:  J Immunol Sci       Date:  2018

Review 3.  Impact of the gut microbiome on mucosal inflammation.

Authors:  Warren Strober
Journal:  Trends Immunol       Date:  2013-08-16       Impact factor: 16.687

Review 4.  TLR5 expression in the small intestine depends on the adaptors MyD88 and TRIF, but is independent of the enteric microbiota.

Authors:  Inês Brandão; Nives Hörmann; Sven Jäckel; Christoph Reinhardt
Journal:  Gut Microbes       Date:  2015-04-29

Review 5.  Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.

Authors:  Connie W Y Ha; Yan Y Lam; Andrew J Holmes
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 6.  Gut microbes and the brain: paradigm shift in neuroscience.

Authors:  Emeran A Mayer; Rob Knight; Sarkis K Mazmanian; John F Cryan; Kirsten Tillisch
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 7.  The microbiome and innate immunity.

Authors:  Christoph A Thaiss; Niv Zmora; Maayan Levy; Eran Elinav
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

8.  Duplicated TLR5 of zebrafish functions as a heterodimeric receptor.

Authors:  Carlos G P Voogdt; Jaap A Wagenaar; Jos P M van Putten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

9.  Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.

Authors:  Nai-Lun Yeh; Che-Yuan Hsu; Tsen-Fang Tsai; Hsien-Yi Chiu
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

Review 10.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.